Search Results for: Pluristem

Pluristem’s Covid-19 Phase 2 Germany trial

Israel’s Pluristem Therapeutics (reported here previously) has been approved by German’s health regulatory authority to conduct a Phase 2 clinical trial of its PLX PAD stem cells on 40 serious Covid-19 patients. Pluristem is already conducting a 140-patient Phase 2 … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Good progress of Pluristem trial

Seven of the eight critically ill coronavirus patients on ventilators, treated with PLX stem cells from Israel’s Pluristem, survived after 28 days.  Only one of those still needed mechanical ventilation – the other five having been discharged from hospital. 10 … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Pluristem’s cells prevented amputation

A patient, with Buerger’s disease was at pre-amputation stage due to non-healing foot ulcers. Regulatory approval was given for compassionate treatment using Pluristem’s PLX-PAD cells. A year after treatment, the wound is fully closed, and the patient has resumed normal … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Pluristem stem cells control the immune system

A new study on stem cells developed by Israeli biotech Pluristem shows they can be used to regulate the immune system, speeding it up or slowing it down as needed. They release a cocktail of therapeutic proteins in response to … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

The Pluristem story

(Thanks to NoCamels) Here again are the details of the stem cell transplants performed by Israeli doctors using PLX stem cells from Israeli biotech Pluristem. Two of the patients were cured completely and one survived for four months until she … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Pluristem saves another bone marrow patient

PLX stem cell therapy by Israel’s Pluristem Therapeutics saved a 54-year old Israeli woman with lymphoma cancer and terminal bone marrow failure at Jerusalem’s Hadassah hospital. The patient failed to respond to chemotherapy or bone marrow transplants. She has now … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

Cell-based cultivated coffee

Israeli biotech Pluri (previously Pluristem) has launched its cell-based coffee. It is estimated to cut water usage by 98% compared to traditional methods of production. Pluri plans to spin out its cell-based coffee as a new subsidiary focused on developing … Continue reading

Posted in Science & Technology | Leave a comment

US NIH funds Israeli radiation therapy

The U.S. National Institutes of Health has granted Israel’s Pluri (previously Pluristem) $4.2 million to develop its PLX-R18 (see here) as a treatment for Hematopoietic Acute Radiation Syndrome – a deadly disease that can result from nuclear disasters and radiation … Continue reading

Posted in Israel's Medical Achievements | Leave a comment

New factory for cultivated meat

Plurinuva / NewCo, the partnership between Tnuva and Pluristem (see here previously), is now rebranding itself under the name Ever After Foods. It has built a production capable of supplying cultured meat products to the market on an industrial scale. … Continue reading

Posted in Economy & Business | Leave a comment

Lab-grown meat industry partnership

Israeli-based Tnuva is investing $7.5 million in partnering Israeli biotech Pluristem Therapeutics. They have formed a joint company NewCo to create meat and dairy products from animal cells, using sustainable technology. https://www.timesofisrael.com/israeli-companies-at-nasdaq-want-to-bring-lab-grown-meat-to-the-masses/ https://www.timesofisrael.com/tnuva-beefs-up-food-tech-operations-with-new-cultured-meat-venture/

Posted in Economy & Business | Leave a comment